title: Serum MIP-1 alpha level: a biomarker for the follow-up of lentiviral therapy in mucopolysaccharidosis IIIB mice.
abstract: Mucopolysaccharidosis (MPS) IIIB is an inherited lysosomal storage disorder caused by deficiency of alpha-N-acetylglucosaminidase (NAGLU). The disease is characterized by mild somatic features and severe neurological involvement, with high mortality rates. Although some therapeutic approaches have been applied to the murine model of the disease, no effective therapy is available. Moreover, assessing therapeutic efficacy is challenged by the lack of markers to for progression and severity. In this study, we examined the effect of brain-directed lentiviral (LV) gene therapy on serum levels of macrophage inflammatory protein 1 alpha (MIP-1alpha) and brain-derived neurotrophic factor (BDNF) proteins in the murine model of MPS IIIB to identify novel serum biomarkers. The cytokine MIP-1alpha was elevated in MPS IIIB mouse serum, and following gene therapy, it was reduced to normal levels. For neurotrophin BDNF, the difference in serum levels between MPS IIIB and normal mice was not statistically significant; after LV gene therapy, an increase in protein was found in treated mice, although the values were not statistically significant. Our studies suggest MIP-1alpha as the first serum biomarker that could be used to monitor disease progression and treatment for MPS IIIB disease.
authors.affiliation: Department of Biochemistry and Medical Biotechnologies, University of Naples Federico II, Via Sergio Pansini n 5, 80131 Naples, Italy. dinatale@unina.it
authors.forename: Paola
authors.initials: P
authors.lastname: Di Natale
authors.forename: Carmela
authors.initials: C
authors.lastname: Di Domenico
authors.forename: Daniele
authors.initials: D
authors.lastname: Di Napoli
mesh_terms: D000118:Acetylglucosaminidase / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D015415:Biomarkers / Q000097:blood*; D001921:Brain / Q000502:physiology; D054405:Chemokine CCL3 / Q000097:blood*; D004195:Disease Models, Animal; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D015316:Genetic Therapy; D016086:Lentivirus / Q000235:genetics*; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains; D009084:Mucopolysaccharidosis III / Q000097:blood / Q000235:genetics / Q000628:therapy; D019076:Transgenes / Q000235:genetics
chemical_list: D015415:Biomarkers; C496534:Ccl3 protein, mouse; D054405:Chemokine CCL3; C033079:alpha-N-acetyl-D-glucosaminidase; D000118:Acetylglucosaminidase